logo
Plus   Neg
Share
Email

NI Expects Q4 Revenues Above Estimates And Guidance - Quick Facts

While announcing preliminary financial results for fourth quarter on Thursday, NI (NATI), formerly National Instruments Corp., said it expects revenue of $367 million, flat year-over-year, and above the high end of its guidance.

The company also expects record quarterly adjusted revenue of $369 million, up 19 percent sequentially.

The company also expects fourth quarter earnings per share to be within guidance and adjusted earnings per share to be at or above the high end of that guidance. Earnings include higher restructuring charges than previously expected.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.12 per share on a revenue decline of 4.9 percent to $349.7 million for the quarter. Analysts' estimates typically exclude special items.

The value of the company's overall orders for the fourth quarter is estimated to be up 7 percent year-over-year. The company estimates positive sequential and year-over-year order growth across all regions as well as in semiconductor, aerospace, defense and government, and portfolio.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year. Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow.
RELATED NEWS
Follow RTT